Study on the Clinical Safe and Effective Methods of Arsenic-Containing Compound-Qinghuang Powder in the Treatment of Myelodysplastic Syndrome

Table 3

Clinical adverse symptoms of group A and group B.

Symptoms	Number of patients (%)
	Group A	Group B
Gastric malaise	1 (4.17)	0
Anorexia and nausea	0	0
Diarrhea	2 (8.33)	2 (8.33)
Numbness of limbs	0	0
Skin keratosis	0	0
Edema	0	0